GlobeNewswire by notified

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF HOYLU AB (PUBL)

Share

N.B. This English text is an unofficial translation of the Swedish original of the notice to attend the Annual General Meeting in Hoylu AB (publ), and in case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF HOYLU AB (PUBL)

The shareholders of Hoylu AB (publ), reg. no 559084-6381 (the “Company”) are hereby summoned to attend the annual general meeting held on Friday June 10, 2022.

INFORMATION RELATED TO THE CORONA VIRUS

Due to the coronavirus and in order to reduce the risk of spreading the infection, the board of directors has, in accordance with the Act (2022:121) in temporary exemptions to facilitate the conduct of general meetings of shareholders and associations, decided that the annual general meeting shall be conducted according to a so-called postal voting procedure. The annual general meeting will thus be held without the possibility for shareholders to attend in person or by proxy. Instead, shareholders may participate on the annual general meeting by voting and submitting questions in advance in accordance with the instructions below.

Information on the resolutions adopted by the annual general meeting will be published on Friday 10 June 2022.

Notification on participation

Shareholders who wish to attend the annual general meeting must:  

  • be recorded as shareholders in the share register maintained by Euroclear Sweden AB on Wednesday June 1, 2022;

  • no later than on Thursday 9 June, 2022, preferably before 16:00 (CEST), have given notice of their participation and potential assistants in accordance with the instructions under “Information about postal voting” below. Participation to attend the annual general meeting shall be sent by e-mail to bolagsstamma@hoylu.com or by mail to Eversheds Sutherland Advokatbyrå AB, Strandvägen 1, 114 51 Stockholm.

Information about postal voting

The postal voting form will be available on the Company’s website www.hoylu.com at least three weeks before the annual general meeting. The completed and signed form should be sent in original to the above address. The completed form must be received by the Company no later than 9 June 2022, preferably before 16.00 CEST. Further instructions can be found in the form.

Please note that registration of shares in your own name (if the shares are nominee-registered) and notification of the meeting must have been made as set out below.

The notification should state name, personal identification number or registration number, address, day-time phone number and when applicable information regarding any representative, proxy and or at most two assistants. If applicable, the notification must include authorization documents such as certificate of registration or equivalent documents.

Nominee-registered shares
Shareholders whose shares are nominee-registered must, in order to have the right to attend the extraordinary general meeting, request to be temporarily registered in the share register kept by Euroclear Sweden AB. The shareholder must instruct their nominee thereof in due time prior to Wednesday 1 June 2022, by which date such registration must be executed.

Counsel etc.

Shareholders represented by proxy shall issue a written and dated power of attorney signed by the shareholder. The power of attorney may not be issued earlier than one year before the date of the general meeting, with the exception of the power of attorney specifies a longer period, up to a maximum of five years. A power of attorney issued by a legal entity shall have a registration certificate attached, or if such certificate does not exist, equivalent documents. Original power of attorney and any registration certificate should, in advance of the general meeting be sent to the Company at the address above. A power of attorney form may be ordered from the Company and are available on the Company’s website www.hoylu.com.

Personal information

Personal data obtained through the notification, counsel or the share register kept by Euroclear will only be used for the necessary registration and preparation of the voting list for the general meeting. For information on the processing of personal data, see Euroclear's privacy policy available at https://www.euroclear.com/sweden/sv/regelverk-Euroclear-Sweden/GDPR.html

PROPOSED AGENDA

  1. Opening of the annual general meeting
  2. Appointment of a chairman of the general meeting
  3. Preparation and approval of the voting register
  4. Appointment of one (1) or two (2) persons to verify the minutes of the meeting
  5. Determination of whether the annual general meeting was duly convened
  6. Approval of the agenda
  7. Presentation of the annual accounts and the auditor's report as well as the consolidated annual accounts and auditor's report on the consolidated accounts
  8. Resolution on:
    1. adoption of the profit and loss account and balance sheet, as well as the consolidated profit and loss account and balance sheet;
    2. appropriations of the Company's profits or losses in accordance with the adopted balance sheet; and
    3. discharge from liability of the Board of Directors and the CEO
  9. Determination of remuneration for the Board of Directors and the auditor
  10. Appointment of Board of Directors and auditor
  11. Resolution to amend terms and conditions for outstanding convertible notes
  12. Resolution on directed issue of convertible notes
  13. Resolution to authorize the Board of Directors to resolve to issue new shares, convertible loan notes and/or warrants
  14. Resolution to authorize the Board of Directors to undertake minor adjustments of the resolutions
  15. Closure of the annual general meeting

PROPOSED RESOLUTIONS

Appointment of a chairman of the general meeting (item 2)

The Chairman of the Board, Johan Lindqvist, is proposed to be appointed as chairman of the annual general meeting.

Preparation and approval of the voting register (item 3)

The proposed voting list is the voting list that will have been drawn up on the basis of the shareholders present, the register of shareholders and postal votes received and that has been checked and approved by the adjusters.

Appointment of one (1) or two (2) persons to verify the minutes of the meeting (item 4)

The board of directors proposes that John Edgren (Eversheds Sutherland Advokatbyrå) or, in his/her absence the person(s) designated by the board of directors, be appointed to approve the minutes together with the chairman. The duties of the person responsible for the minutes shall also include checking the voting list.

Appropriations of the Company's profits or losses in accordance with the adopted balance sheet (item 8b)

The Board proposes that all retained earnings and profit from the financial year 2021 is carried forward. The Board proposes no dividend for the financial year 2021.

Determination of remuneration for the Board of Directors and the auditor (item 9)

A remuneration of totalling SEK 700,000 is to be distributed to the Board of Directors, of which SEK 250,000 is to be distributed to the Chairman of the Board and SEK 150,000 each to the other Directors appointed by the annual general meeting. A Director who at the same time is employed by the Company shall not receive any director’s fee.

Remuneration to the auditor are to be paid according to current account and approved invoices.

Appointment of Board of Directors and auditor (item 10)

It is proposed that the number of Directors, until the end of the next annual general meeting, shall consist of four (4) Directors and no deputies.

It is proposed to re-elect Johan Lindqvist (chairman) and re-elect each of Reidar Fougner, Fredrik Urbanski and and Hans Othar Blix as Directors in the Company.

The Board further proposes that the registered auditing firm Deloitte AB be re-elected to serve for the period until the end of the next annual general meeting (with authorized public accountant Henrik Ekström as auditor-in-charge until further notice).

Complete information of the Directors of the Board and accountant will be published on the Company’s website three weeks before the annual general meeting at the latest.

Resolution to amend terms and conditions for outstanding convertible notes (item 11)

The board of directors proposes that the annual general meeting resolves to reduce the conversion price and change the terms and conditions for outstanding convertible notes from SEK 1.50 per new share to SEK 1.00 per new share as set out below.

Current wordingProposed wording
8.2 Konverteringskursen ska motsvara 1,50 kronor per Ny Aktie.



The Conversion Price shall correspond to 1.50 SEK per New Share.
8.2 Konverteringskursen ska motsvara 1,00 krona per Ny Aktie.



The Conversion Price shall correspond to 1.00 SEK per New Share.

Resolution on directed issue of convertible notes (item 12)

The shareholder Alden AS proposes that the annual general meeting resolves on a directed issue of convertible notes in a nominal amount not exceeding SEK 15,000,000, entailing an increase in the share capital of not more than SEK 1 236 585 upon full conversion of the convertible notes. The resolution shall otherwise be governed by the following terms and conditions.

  1. The right to subscribe for the convertible notes shall vest in Fougner Invest AS (controlled by Reidar Fougner), Trellevika Invest AS (controlled by Reidar Fougner 's wife), Fredrik Fougner (son of Reidar Fougner), TTC Invest AS (controlled by Fredrik Urbanski), Skadi AS (controlled by Hans Othar Blix), Windchange Invest AB (controlled by Johan Lindqvist), Baklid Invest AS (controlled by Truls Baklid) and CeWi Invest AS (controlled by Karl Wiersholm). The reason for deviating from the shareholders’ pre-emption rights is to enable investments in the Company from the board members Reidar Fougner, Fredrik Urbanski, Hans Othar Blix, Johan Lindqvist and members of the Company’s management, Truls Baklid and Karl Wiersholm and to achieve alignment with the Company’s shareholders. Furthermore, the Company can raise capital in a time- and cost-efficient manner through a directed issue.
  2. The nominal amount of the convertible note shall be SEK 1 or integral multiples thereof. The notes carry an annual interest rate of 6 per cent in accordance with the provisions set out in the terms and conditions, Appendix 1A.
  3. The subscription price shall be equal to the nominal amount of the convertible notes.
  4. Subscription shall take place within three (3) days of the date of the resolution to issue the convertible notes. Payment for the subscribed convertible notes shall be made within one (1) week of the time of subscription.
  5. The convertible notes may be converted into shares during the period commencing on the date of registration, at the Swedish Companies Registration Office, of the resolution regarding the issue up to, and including, October 31, 2022, at a conversion price of SEK 1.00.
  6. Any share premium shall be transferred to the unrestricted premium reserve.

Share capital, shares, and dilution

Provided that the annual general meeting resolves in accordance with Alden AS proposal and upon full conversion of the convertible notes (excluding accrued interest) the share capital will increase by an additional amount of approximately SEK 1,236,585 by the issue of 15,000,000 new shares. The dilution for existing shareholders amount to a maximum of approximately 14,0 per cent.

A valid resolution pursuant to this item requires that the resolution be supported by shareholders representing at least nine-tenths (9/10) of both the votes cast and the shares represented at the annual general meeting

Resolution regarding authorizing the Board of Directors to resolve to issue new shares, issue convertible loan notes and/or issue warrants (item 13)

The board of directors proposes that the general meeting authorizes the Board to resolve, on one or more occasions, during the period and until the end of the next annual general meeting, to increase the Company’s share capital through new issue of shares, convertible loan notes, and/or warrants to the extent permitted by the Articles of Association from time to time.

New issue of shares, as well as issue of warrants and convertible loan notes, shall be able to take place with or without deviation from the shareholders’ pre-emption right, against cash payment, for payment in kind, by way of set-off, or on conditions following from Chapter 2, Section 5 of the Swedish Companies Act. According to Chapter 16 of the Swedish Companies Act, this authorization does not authorize the board of directors to resolve on issue to Board Directors and/or employees of the Company.

A valid resolution pursuant to this item requires that the resolution be supported by shareholders representing at least two-thirds (2/3) of both the votes cast and the shares represented at the annual general meeting.

Resolution to authorize the Board of Directors to undertake minor adjustments of the resolutions (item 14)

The Board proposes that the annual general meeting authorizes the Board, the CEO or the person otherwise designated by the Board, to undertake such minor adjustments and clarifications of the decisions made at the annual general meeting to the extent required for registration of the resolutions.


OTHER

Number of shares and votes in the Company

As of the date of this notice, the total number of shares in the Company is 91,743,922, representing a total of 91,743,922 votes. The Company holds no own shares.

Shareholders’ right to information

Shareholders are informed of their right under Chapter 7, Section 32 of the Swedish Companies Act to request information about circumstances that may affect the assessment of an item of business on the agenda and about circumstances that may affect the assessment of the Company's financial situation. The Board and the CEO shall provide such information if the Board considers that this can be done without significant damage to the Company. The duty of disclosure also applies to the Company's relationships with other companies in the group, the consolidated financial statements and such circumstances as detailed above applicable to subsidiaries.

Shareholders have a right to ask the Company questions at the annual general meeting on the items and proposals to be considered at the annual general meeting.

Documents

The annual accounts, consolidated annual accounts, auditor's report and other documents related to the resolutions proposed to the annual general meeting will be available at the Company’s head office and on the Company’s webpage, www.hoylu.com, no later than three weeks prior to the annual general meeting and will also be sent to those shareholders who so request and provide their postal address. The documents will also be available at the annual general meeting.

____________________________

Stockholm in May 2022

Hoylu AB (publ)

The Board of Directors

For more information, please contact:
Truls Baklid, CEO, +47 924 38 900 Email: tob@hoylu.com
Karl Wiersholm, CFO at Hoylu +1 425 829 2316 Email: kw@hoylu.com

About Hoylu

Hoylu's Adaptive Workspace opens up a new way for teams to plan, build and engage --so they get the impact they want no matter the industry, department or time. Whatever your management or planning style, Hoylu fits the way you structure your team and integrates all the productivity tools you're already using. So, you easily plan and complete any project. And when it comes to the work itself, Hoylu gives your team the freedom to drag and drop anything from documents to presentations, and even video conferences. So, anyone can easily share and embed live files for the entire team to work on --all from anywhere, on any device.

For more information: www.hoylu.com

Try Hoylu for free: https://app.hoylu.com/

Ticker symbol: Hoylu
Marketplace: Nasdaq First North Growth Market
Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550, ca@mangold.se

Publication
The information was submitted for publication, through the agency of the contact person set out above, at 08:40 CEST on May 2, 2022.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

FRO – Private acquisitions of Euronav shares in exchange for Frontline shares completed28.5.2022 12:01:09 CEST | Press release

FRO – Private acquisitions of Euronav shares in exchange for Frontline shares completed Frontline Ltd. (“Frontline” or the "Company") (NYSE: FRO – OSE: FRO) announces that it has agreed to acquire a total of 5,955,705 shares in Euronav N.V. (NYSE: EURN & Euronext: EURN) (“Euronav”) representing 2.95% of the outstanding shares in privately negotiated share exchange transactions with certain shareholders of Euronav N.V. where such shareholders of Euronav N.V. receive consideration shares in Frontline. Frontline will issue a total of 8,337,986 new shares as a result of these transactions, equivalent to an exchange ratio of 1.4. Frontline will be entitled to the declared USD 0,06 dividend to be paid by Euronav on the acquired shares on 8 June 2022. Settlement is expected to take place on or about 1 June 2022 by delivery of existing shares through a share lending arrangement with Frontline's main shareholder Hemen Holding Ltd. Following completion of the issue of the new Frontline shares, F

FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma28.5.2022 00:58:29 CEST | Press release

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1 Sustained clinical benefit from Kymriah treatment demonstrated – of patients who achieved a complete response, 85% were still in response at 12 months1 Kymriah can be administered in the outpatient setting, offering increased flexibility and potentially reducing the burden of therapy for patients and their care teams1,2 Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings1 Basel, May 28, 2022 — Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah® (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory (r/r) follicular lymphoma (FL) after two or more lines of systemic therapy. In accordance with the Accelerated Approval Program, continued approval for this indicati

ObsEva Announces Corporate Updates27.5.2022 22:01:00 CEST | Press release

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland– May 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, announced today that it has entered into a waiver and amendment agreement (Amendment Agreement) with respect to its amended and restated securities purchase agreement (Securities Purchase Agreement) with certain funds and accounts managed by JGB Management, Inc. (JGB), which is structured to provide up to $135 million in borrowing capacity, available in nine tranches. The third tranche under the Securities Purchase Agreement was due to be funded on May 25, 2022. However, the tranche has not been funded as a result of ObsEva not meeting the funding condition that its volume-weighted average share price would not trade below $3.00 per share for five or more trading days during the 30 days prior to the funding date for the third tranche. Pursuant to the Am

CONDITIONS FOR PURCHASES OF CORPORATE BONDS27.5.2022 16:20:00 CEST | Press release

Bid procedure, 2022-06-01BondsBonds issued in SEK by Swedish non-financial undertakings. The following bonds are eligible for delivery: HEMSO FASTIGHETS AB: XS2173253407, 2025-05-13 HEMSO FASTIGHETS AB: XS2269194572, 2023-12-07 VASAKRONAN AB: SE0010599183, 2023-12-20 VASAKRONAN AB: XS2391917205, 2025-03-28 ESSITY AB: XS2355204608, 2025-01-17 SCANIA CV AB: XS2297918349, 2023-11-11 SCANIA CV AB: XS2382157571, 2024-09-02 ELECTROLUX AB: XS2152294679, 2023-04-06 ELECTROLUX AB: XS1969611943, 2024-03-27 Delivery of a Bond may not occur if the Counterparty has purchased the Bond from the issuer more recently than one month prior to the date of announcement of the Special terms, that is, the purchase may not have taken place after: 2022-04-27Bid date2022-06-01Bid times10.30-11.30 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)XS2173253407: 30 mln SEK +/-30 mln SEK XS2269194572: 30 mln SEK +/-30 mln SEK SE0010599183: 30 mln SEK +/-30 mln SEK XS2391917205: 30 mln SEK +/-

CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS27.5.2022 16:20:00 CEST | Press release

Bid procedure, 2022-06-03BondsSWEDEN I/L BOND: 3113. SE0009548704. 2027-12-01 SWEDEN I/L BOND: 3114, SE0013748258, 2030-06-01 Bid date2022-06-03Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)3113: 250 mln SEK +/-125 mln SEK 3114: 250 mln SEK +/-125 mln SEK Highest permitted bid volume (corresponding nominal amount)3113: 250 mln SEK per bid 3114: 250 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 10.15 (CET/CEST) on the Bid dateDelivery and payment date2022-06-08Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2022-05-27 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be